What's new? Log in Free sign up

Anbio Biotechnology Class A Ordinary Shares (NNNN)

Company Profile

Company profile

Ticker

NNNN

Exchange

Incorporated

Fiscal year end

Industry (SIC)

In Vitro & In Vivo Diagnostic Substances

Ortho Clinical Diagnostics • QuidelOrtho • IDEXX Laboratories • Myriad Genetics • Neogen • Celldex Therapeutics • Lantheus • Meridian Bioscience • Lucira Health • Heska Corp. ...

SEC CIK

NNNN stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Anbio Biotechnology Announces Closing of Initial Public Offering

Prospectus supplement with pricing info

Notice of effectiveness

Certification of approval for exchange listing

Registration of securities on exchange

Registration statement (foreign) (amended)

Registration statement (foreign) (amended)

Free writing prospectus

Registration statement (foreign) (amended)

Registration statement (foreign)

Latest ownership filings

No filings

News

From Benzinga Pro

Preview: Anbio Biotechnology Set To IPO Tomorrow

Press releases

From Benzinga Pro

Anbio Biotechnology Announces Closing of Initial Public Offering

Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the "Company" or "Anbio"), a global diagnostic company dedicated to the advancement of medical technology and the provision of in vitro

Anbio Biotechnology Announces Pricing of Initial Public Offering

Frankfurt am Main, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the "Company" or "Anbio"), a global diagnostic company dedicated to the advancement of medical technology and the provision of in vitro

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.